These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neuromuscular blockade in adult intensive care. Topulos GP New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424 [TBL] [Abstract][Full Text] [Related]
24. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels. Hill L Dimens Crit Care Nurs; 1995; 14(6):305-14. PubMed ID: 8631213 [TBL] [Abstract][Full Text] [Related]
25. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions. Davidson JE New Horiz; 1994 Feb; 2(1):75-84. PubMed ID: 7922432 [TBL] [Abstract][Full Text] [Related]
26. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Johnson PN; Miller J; Gormley AK Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445 [TBL] [Abstract][Full Text] [Related]
27. Monitoring neuromuscular blockade in the critically ill. Barnette RE; Fish DJ Crit Care Med; 1995 Oct; 23(10):1790-1. PubMed ID: 7587250 [No Abstract] [Full Text] [Related]
29. Neuromuscular-blocking drugs. Use and misuse in the intensive care unit. Murphy GS; Vender JS Crit Care Clin; 2001 Oct; 17(4):925-42. PubMed ID: 11762268 [TBL] [Abstract][Full Text] [Related]
31. [Use of the muscle relaxant in the intensive care unit]. Nakatsuka H; Shimizu K; Sato T Masui; 2008 Jul; 57(7):853-9. PubMed ID: 18649640 [TBL] [Abstract][Full Text] [Related]
32. Review of Continuous Infusion Neuromuscular Blocking Agents in the Adult Intensive Care Unit. Smetana KS; Roe NA; Doepker BA; Jones GM Crit Care Nurs Q; 2017; 40(4):323-343. PubMed ID: 28834856 [TBL] [Abstract][Full Text] [Related]
33. A review of neuromuscular blockade in the critically ill patient. Michaud D; Abbas M; Gélinas C Dynamics; 2002; 13(3):11. PubMed ID: 12640839 [No Abstract] [Full Text] [Related]
34. The use of muscle relaxants in the intensive care unit. Sharpe MD Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224 [TBL] [Abstract][Full Text] [Related]
35. Current recommendations for monitoring depth of neuromuscular blockade. Lien CA; Kopman AF Curr Opin Anaesthesiol; 2014 Dec; 27(6):616-22. PubMed ID: 25251919 [TBL] [Abstract][Full Text] [Related]
36. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine. Shapiro BA; Warren J; Egol AB; Greenbaum DM; Jacobi J; Nasraway SA; Schein RM; Spevetz A; Stone JR Crit Care Med; 1995 Sep; 23(9):1601-5. PubMed ID: 7664564 [TBL] [Abstract][Full Text] [Related]
37. Monitoring of peripheral nerve stimulation versus standard clinical assessment for dosing of neuromuscular blocking agents. Murray MJ Crit Care Med; 1997 Apr; 25(4):561-2. PubMed ID: 9142016 [No Abstract] [Full Text] [Related]
38. Peripheral nerve stimulation and clinical assessment for dosing of neuromuscular blocking agents in critically ill patients. Tavernier B; Rannou JJ; Vallet B Crit Care Med; 1998 Apr; 26(4):804-5. PubMed ID: 9559623 [No Abstract] [Full Text] [Related]
39. Conceptual and technical insights into the basis of neuromuscular monitoring. Naguib M; Brull SJ; Johnson KB Anaesthesia; 2017 Jan; 72 Suppl 1():16-37. PubMed ID: 28044330 [TBL] [Abstract][Full Text] [Related]
40. A new nerve stimulator for monitoring neuromuscular blockade and performing nerve blocks. Zeh DW; Katz RL Anesth Analg; 1978; 57(1):13-7. PubMed ID: 147039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]